Analytical procedures for contaminant and nutrient analyses
Total Hg concentrations in umbilical cord blood samples were determined using cold vapour atomic absorption spectrometry (Pharmacia Model 120; Pharmacia, Piscataway, NJ, USA). Cord blood Pb levels were determined by graphite furnace atomic absorption with Zeeman background correction (Perkin Elmer model ZL 4100; Perkin Elmer, Norwalk, CT, USA). PCB congeners were measured in purified cord and child plasma extracts using gas chromatography (HP 5890 Series II Plus) equipped with a 30-m long DB-5 capillary column (J&W Scientific, Folsom, CA, USA) and HP 5890B mass spectrometer (Agilent) according to the method described by Dallaire et al. (2009) . The 14 most prevalent PCB congeners [International Union of Pure and Applied Chemistry (IUPAC) nos. 28, 52, 99, 101, 105, 118, 128, 138, 153, 156, 170, 180, 183, 187) were measured in purified cord plasma extracts using high-resolution gas chromatography (Hewlett-Packard HP5890A; Hewlett-Packard, Palo Alto, CA, USA), with two capillary columns (Hewlett-Packard Ultra I and Ultra II) and dual Ni-63 electron capture detectors. For the present study, PCB congener 153, expressed on a lipid basis, was used as an indicator of total PCB exposure. Cord Se concentrations were determined by inductively coupled plasma mass spectrometry (ICP-MS) on a Perkin Elmer Sciex Elan 6000 instrument.
Total Hg, Pb, and Se concentrations in child blood samples were determined by ICP-MS (Perkin Elmer Sciex Elan 6000 ICP-MS instrument for Pb and Se; PE DRC II instrument for Hg). The limits of detection for cord sample analyses were 0.2 µg/L for blood Hg and Pb, 0.1 µmol/L for blood Se, and 0.02 µg/L for all PCB congeners in plasma. Limits of detection for child blood sample analyses were 0.1 µg/L for Hg, 0.002 µg/dL for Pb, 0.09 µmol/L for Se, and were less than 0.05 µg/L for all PCB congeners except for PCB-52 (0.15 µg/L). A value equal to 3 half the limit of detection of the analytical method was entered in the database whenever a substance was not detected (child Hg: n = 1; other substances were detected in all samples).
Total phospholipids were isolated from the lipid extract by thin-layer chromatography using heptane:isopropyl ether:acetic acid (60:40:3, v/v/v) as the developing solvent. After transmethylation using BF3/methanol, the fatty acid profile was determined by capillary gasliquid chromatography. Concentrations of docosahexaenoic acid (DHA) in cord and at time of testing were expressed as percentages of the total area of all fatty acid peaks from C14:0 to C24:1 (percent weight). Table S1 . Results from linear regression analyses for the relation of contaminants to TRF symptom scores using a forward strategy for covariate selection.
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